Abstract: The present invention provides a composition for improving intestinal microbial flora, the composition comprising: a ginseng extract or a fraction thereof; and sodium propionate. The composition for improving intestinal microbial flora of the present invention is capable of increasing the proportion of beneficial bacteria in intestinal microbial flora by promoting the growth of beneficial bacteria while inhibiting the growth of harmful bacteria, and accordingly, the composition of intestinal microbial flora can be improved and the balance thereof maintained, ultimately assisting in improving the health of the body, such as by strengthening immunity and improving skin texture.

Abstract: Provided is a composition for reforming skin microbiota comprising a ginseng extract; a ginseng-derived antibacterial agent; and alkanediol, to increase the fraction of beneficial bacteria in skin microbiota by promoting the growth of beneficial bacteria and inhibiting the growth of harmful bacteria, whereby the constitution of skin microbiota is reformed and maintained in a balanced state, ultimately helping improve human skin health.

Abstract: Provided are a lactic acid bacteria culture medium comprising red ginseng-derived dietary fiber; and a method for culturing lactic acid bacteria by using same, wherein red ginseng-derived dietary fiber is used in a lactic acid bacteria culture medium so that the number of viable lactic acid bacteria can be increased and the culturing thereof can be improved, and the method uses the culture medium so as to improve culturing under the same conditions, and thus is advantageous in terms of cost.

Abstract: The present invention relates to a composition and health functional food for preventing and treating a respiratory inflammation disease using a mixed herbal mixture. Through various experiments, for example, determination of the cell number of BAL (bronchoalveolar lavage) (Experimental Example 1); Determination of CD11b+/Gr-1+ ratio in leukocyte within BAL fluid (Experimental Example 2); Determination of expressed RNA level of inflammatory cytokines in lung tissue (Experimental Example 3); Determination of expressed RNA level of inflammatory cytokines in BALF (Experimental Example 4); Lung histology (Experimental Example 5); Brief Clinical test (Experimental Example 7) etc, it has been verified that the inventive combined extract showed more potent inhibiting effect on respiratory inflammation disease than each herb extract.